AASB 1023 - General Insurance Contracts - July 2004

AASB 1023 rests on a small set of core measurement and presentation concepts that determine how an insurer recognises income and liabilities and how it discloses risk.

1. Attachment date and pattern of incidence of risk (s 4.2-4.4). Premiums are earned from the attachment date, the point at which the insurer accepts risk (defined in s 19.1). Premium revenue is allocated over the period of the contract (or period of indemnity for reinsurance) in accordance with the estimated pattern of exposure to insured events (s 4.3). For many one-year direct contracts, the pattern may be linear; for other contracts or reinsurance treaties the pattern can be multi-year and requires explicit estimation (s 4.4.4-4.4.11).

2. Outstanding claims liability measured as central estimate plus risk margin (s 5.1-5.1.6). The outstanding claims liability is the present value of expected future payments for claims incurred plus an additional risk margin to reflect uncertainty. The central estimate is the mean of the distribution of possible outcomes (s 5.1.4). The risk margin is to reflect the insurer’s business characteristics, data quality and model robustness (s 5.1.7-5.1.9). The Standard contemplates entity-level and class-level treatment of margin and provides that the risk margin is applied to net outstanding claims for the entity as a whole but may be estimated by class (s 5.1.8-5.1.9).

3. Discounting using risk-free observable rates (s 6.1). The outstanding claims liability is to be discounted for time value of money using risk-free discount rates based on current observable objective rates that match the nature, structure and term of the obligations (s 6.1, 6.1.2). Government bond rates are cited as a typical starting point (s 6.1.2). The Standard also allows that for short-duration claims (expected settled within one year) discounting may be unnecessary if present value differs insignificantly from undiscounted amounts (s 5.1.2-5.1.3).

4. Unearned premium liability and liability adequacy test (s 7.1 and s 9.1). Premiums not yet recognised as revenue are held as an unearned premium liability to meet future claims and deferred acquisition costs (s 7.1). The liability adequacy test requires assessment of the present value of expected future cash flows for future claims on current contracts plus an appropriate risk margin and compares that to the carrying amount of the unearned premium liability less related deferred acquisition costs and related intangible assets; any deficiency is recognised immediately in profit or loss, with specified write-down ordering (s 9.1).

5. Presentation on a gross basis and treatment of reinsurance (s 10.1-11.1). Cedants must present premiums and claims gross (s 10.1-10.1.3). Reinsurance premiums ceded are recognised as outwards reinsurance expense and reinsurance recoveries are recognised as income and assets rather than being offset against claims (s 10.1.3, s 11.1). Impairment of reinsurance assets is recognised only when there is objective evidence of an event after initial recognition that reduces recoverable amounts with a reliably measurable impact (s 12.1.1).

6. Asset measurement choice to reduce measurement mismatches (s 15.2-15.5). The Standard requires or permits designation of financial assets that back insurance liabilities as fair value through profit or loss under AASB 9 where permitted, on first application or recognition (s 15.2). Investment property backing liabilities is measured at fair value under AASB 140 (s 15.3), and PPE backing liabilities is measured under the revaluation model in AASB 116 (s 15.4). The intention stated is to reduce measurement inconsistency between insurance liabilities measured on a current information basis and assets measured at amortised cost (s 15.2.2).

7. Unbundling deposit components and embedded derivative rules (s 2.3.1-2.4.4). Contracts that contain both insurance and deposit components may need to be unbundled if the deposit component can be measured separately and the insurer’s accounting policies do not require recognition of the deposit obligations (s 2.4.1). AASB 9 governs embedded derivatives in general insurance contracts unless the embedded derivative is itself an insurance contract, but a limited exception applies for fixed surrender-value options (s 2.3.1-2.3.2).

8. Disclosure emphasis (Part 17). The Standard imposes detailed disclosure requirements: underwriting result, components of net claims incurred (including discount movements reported separately), the central estimate and risk margin with percentage and probability of adequacy and the process for setting the risk margin, claims development tables for long-tail classes, sensitivity analyses or qualitative sensitivity discussion, and full reconciling movements in insurance liabilities and related assets (ss 17.1-17.9). Transitional reliefs are provided for comparative periods (ss 18.1-18.3).

These concepts make explicit that measurement requires significant actuarial judgement (s 4.4.3, 5.1.1), data and model robustness (s 5.1.7), and management disclosures about the methods and key assumptions (ss 17.6, 17.7). The Standard is to be read alongside AASB 9, AASB 13, AASB 3 and other standards which shape treatment of financial instruments, fair value and business combinations (Compilation Details, s 3.1).

AASB 1023 affects the following parties directly and indirectly, by the language of the Standard itself.

• Insurers and reinsurers that write general insurance contracts. The Standard explicitly applies to general insurance contracts and general reinsurance contracts that a general insurer issues and to general reinsurance contracts that it holds (s 2.1(a), 2.1.4). It also uses the terms “insurer”, “cedant” and “reinsurer” in definitions (s 19.1).

• Registered Health Benefits Organisations (RHBOs). Paragraph 2.1.2 specifically requires RHBOs registered under the National Health Act 1953 to apply AASB 1023 to contracts that meet the definition of a general insurance contract and to certain assets backing general insurance liabilities.

• Not-for-profit and AusCF entities. The AusCF paragraphs apply only to not-for-profit entities and to for-profit entities that do not apply the Conceptual Framework for Financial Reporting (AusCF1). The compilation includes AusCF material and a distinction that entities applying the Conceptual Framework shall not apply AusCF paragraphs (AusCF1). This means some measurement and disclosure judgment may differ for AusCF entities.

• Finance, actuarial and audit professions. The Standard requires actuarial inputs and valuations for central estimates and risk margins (s 5.1.1-5.1.9), discount rate selection (s 6.1), impairment assessments for reinsurance assets (s 12.1.1), and extensive disclosures (Part 17). Auditors will need to evaluate these judgements and methods.

• Investors, analysts, regulators and rating agencies. The Standard changes presentation (gross reporting of premiums and claims, separate reporting of recoveries, separate disclosure of central estimate and risk margin , s 11.1; s 17.2) and forces more granular risk information (claims development, sensitivity analyses, concentration risks , s 17.7). These users will see different revenue, expense and liability patterns and additional quantitative and qualitative disclosures.

• Systems and treasury functions. AASB 1023 requires designation of assets backing insurance liabilities as fair value through profit or loss under AASB 9 when permitted (s 15.2), and measurement choices for investment properties and PPE backing liabilities (ss 15.3-15.4). This affects treasury and investment accounting, valuation processes and potentially hedging strategies.

• Parties to portfolio transfers, business combinations and coinsurance/underwriting pools. Sections 13 and 14 set out accounting for portfolio transfers, acquisitions and the allocation of business placed through pools or coinsurance arrangements. For example, if responsibility for claims remains with the transferring insurer, the transfer is treated as reinsurance (s 13.1).

Indirectly affected parties include policyholders and brokers. Recognition timing for premium revenue (s 4.2-4.4) and the treatment of premiums in advance (s 4.2.5) can affect reported profitability and reserves that regulators and customers scrutinise. Cedants dealing with reinsurers must provide information to support reinsurers’ estimates (s 4.4.7-4.4.9, 5.2.12), which influences operational interactions.

Finally, legislative and standards-setters are implicated because the compilation shows an extensive amendment history and interaction with AASB 17, which is scheduled to supersede AASB 1023 for reporting periods beginning on or after 1 July 2026 (Compilation Details, Table note x). Preparers therefore must manage both present compliance and transition planning.

The Standard sets out specific duties for entities preparing financial statements and prescribes particular recognition and measurement positions. The duties are principally those of measurement, presentation and disclosure; there are no rights in the sense of statutory entitlements. Key duties are:

• Recognise premium revenue from the attachment date once reliably estimable and allocate it over the contract period according to the pattern of incidence of risk (s 4.2, s 4.3). The insurer must estimate total premium expected, claims expected, the pattern of incidence and then recognise premium in line with that pattern (s 4.4.2).

• Recognise an outstanding claims liability for both direct and reinsurance business measured as the present value of expected future payments for claims incurred plus a risk margin to reflect inherent uncertainty (s 5.1, 5.1.6).

• Adopt a central estimate for outstanding claims measured as the mean of the distribution of possible outcomes (s 5.1.4). When relying on case estimates for reported claims, adjust those estimates where the mode differs from the mean so case estimates approximate the central estimate (s 5.1.5).

• Include future claims costs such as unpaid reported claims, IBNR, IBNER and claims handling costs (direct and the portion of indirect attributable to current claims) in expected future payments (s 5.2, 5.2.1-5.2.3).

• Discount expected future claim payments using risk-free discount rates based on observable market rates that relate to the nature, structure and term of obligations (s 6.1, 6.1.1-6.1.2). For short-term settlements where present value is not materially different, discounting may not be necessary (s 5.1.2-5.1.3).

• Maintain an unearned premium liability for premiums not yet recognised and perform a liability adequacy test that compares present value of expected future cash flows (including risk margin) with unearned premiums less related intangible assets and deferred acquisition costs (s 7.1; s 9.1). If deficient, recognise the entire deficiency in profit or loss; write-down ordering is specified (s 9.1).

• Defer and amortise acquisition costs as assets where they can be reliably measured and are probable of giving rise to premium revenue to be recognised in future periods; amortise systematically in line with incidence of risk (s 8.1).

• Present transactions on a gross basis for cedants so that premiums, claims and outwards reinsurance expense are visible and not netted off against premium revenue (s 10.1-10.1.3). Recognise reinsurance recoveries and non-reinsurance recoveries as income and assets, not netted against claims (s 11.1).

• Test and recognise impairment of reinsurance assets when there is objective evidence from an event post initial recognition that the cedant may not receive the amounts due and the event has a reliably measurable impact (s 12.1.1).

• Designate, on first application or initial recognition, financial assets that back insurance liabilities and are within scope of AASB 9 and permitted to be FVPL, as fair value through profit or loss; measure investment property backing liabilities at fair value (s 15.2-15.3).

• For portfolio transfers and business combinations, measure insurance liabilities assumed at fair value at acquisition date in accordance with AASB 3 and optionally split the fair value into insurance liability plus an intangible asset representing the difference (s 13.3.1).

• Make specific disclosures about underwriting results, net claims incurred movements (separating current-period and reassessment of prior periods), central estimate and risk margin with percentage and probability of adequacy, processes used to determine the risk margin, sensitivity analyses or qualitative sensitivities, claims development (for long-tail classes), and reconciling movements in insurance liabilities and reinsurance assets (Part 17).

There are operational duties implicit in these measurement rules: insurers must develop methodologies and controls to calculate central estimates and risk margins, select risk-free discount curves (s 6.1.2), identify and unbundle deposit components where required (s 2.4.1-2.4.4), and perform the liability adequacy test at portfolio level (s 9.1).

Rights are implicit in election options where the Standard permits choice: for example, the insurer may elect to unbundle deposit components only in certain circumstances (s 2.4.1(b)), and AASB 1 allows designation of assets at FVPL on first-time adoption (s 15.2.1). Where financial guarantee contracts have been previously treated as insurance contracts, the issuer may elect to apply either AASB 9 or this Standard (s 2.2(f)), but the election is irrevocable on a contract-by-contract basis.

Collectively, these duties change reporting incentives and require insurers to document assumptions and methodologies, because the Standard requires disclosures that will expose the magnitude and drivers of reserve estimates and sensitivities to users (ss 17.6-17.8).

The Standard itself contains no explicit civil or criminal sanctions or enforcement mechanics. AASB 1023 is an Australian Accounting Standard; it prescribes recognition, measurement and disclosure rules and is to be read in conjunction with other standards such as AASB 1048 and AASB 1057 (Compilation Details; s 1.1). Enforcement in practice operates through several channels outside the text of the Standard:

• Auditor review. Preparers’ compliance with AASB 1023 will be assessed by external auditors against the requirements set out in the Standard. The Standard specifies required measurements and disclosures (Part 17, e.g. s 17.2-17.8) and recognised methods (e.g. central estimate plus risk margin s 5.1), which auditors will test for reasonableness and consistency.

• Regulatory oversight. The Standard will be used by prudential and financial regulators as part of their review of insurers’ reported results and capital adequacy, although the Standard does not itself create regulatory powers. The compilation notes interactions with the Insurance Act 1973 for non-insurance contracts regulated under that Act (s 16.1). Regulatory supervisors may also require compliance as part of licensing conditions, but such enforcement measures are outside the Standard’s text.

• Market discipline. Investors, analysts and rating agencies will use the Standard’s mandated disclosures (Part 17) to inform investment and credit assessments. Material misstatement or inadequate disclosures invite adverse market reactions, restatements, or reputational consequences.

• Legal and corporate consequences. While the Standard does not provide statutory penalties, entities that misstate financial information may face consequences under the Corporations Act, continuous disclosure laws or common law (not specified in the Standard). The Standard itself does not specify these legal consequences and names no enforcement bodies.

Because the Standard contains subjective measurement tasks (central estimate, risk margin, discounting choices, probability of adequacy , ss 5.1, 6.1, 17.2(d)), non-compliance or weak documentation can lead to audit qualifications, regulator queries or investor litigation; the document does not list any litigation examples or remedies (Litigation History section below notes the Standard contains no case law references). Entities should therefore expect enforcement through accounting, auditing and regulatory frameworks rather than through penalties contained in the Standard text.

AASB 1023 is an accounting standard and is explicitly designed to be read with, and shaped by, other Australian Accounting Standards and certain legislation. The compilation details and explicit cross-references in the Standard identify several concrete interactions:

• AASB 9 Financial Instruments. AASB 9 governs classification and measurement of financial assets and liabilities, embedded derivatives and financial guarantee contracts. AASB 1023 defers to AASB 9 for embedded derivatives (s 2.3.1), requires designation of deposit components and financial assets that back insurance liabilities at fair value through profit or loss where permitted (s 2.4.4, s 15.2), and treats non-insurance contracts regulated under the Insurance Act 1973 under AASB 9 to the extent they give rise to financial assets or liabilities (s 16.1). The interplay aims to avoid accounting mismatches (s 15.2.2).

• AASB 13 Fair Value Measurement and AASB 140 Investment Property. AASB 1023 requires investment properties backing general insurance liabilities to be measured using the fair value model under AASB 140 and AASB 13 (s 15.3). This requires insurers to apply fair value methodology and related disclosures for such properties.

• AASB 3 Business Combinations. For business combinations involving insurance contracts, AASB 1023 requires measurement at fair value at the acquisition date in compliance with AASB 3 (s 13.3.1). The Standard permits an expanded presentation that splits the fair value of acquired insurance contracts into an insurance liability and an intangible asset (s 13.3.1-13.3.3).

• AASB 116 Property, Plant and Equipment. Where PPE backs general insurance liabilities, AASB 1023 requires measurement under the revaluation model of AASB 116 (s 15.4).

• Insurance Act 1973. AASB 1023 acknowledges that certain contracts may be regulated by the Insurance Act and treats non-insurance contracts regulated under that Act as non-insurance contracts that nonetheless fall under the scope for financial instrument accounting under AASB 9, with FVPL designation where permitted (s 16.1).

• AASB 1048 and AASB 1057. The compilation details direct that AASB 1023 is to be read in the context of other Australian Accounting Standards including AASB 1048 Interpretation of Standards and AASB 1057 Application of Australian Accounting Standards (Compilation Details). These guide the application hierarchy and interpretation.

• AASB 17 Insurance Contracts. The compilation notes that AASB 17 has been made and will supersede and repeal AASB 1023 for reporting periods beginning on or after 1 July 2026 (Compilation Details, Table note x). AASB 17 introduces a comprehensive new measurement model for insurance contracts; the presence of AASB 17 affects transition planning and may create temporary coexistence or phased adoption issues.

• Corporations Act and prudential regulation. While AASB 1023 itself does not set statutory penalties, the Standard’s outputs will feed into statutory reports and regulatory capital assessments under prudential rules, and interaction with Corporations Act continuous disclosure and financial reporting obligations is implicit. The Standard references that some levies and charges (e.g. workers’ compensation) are expenses of the insurer and not amounts collected on behalf of insureds (s 4.2.2), which has tax and regulatory implications.

• Taxation and indirect taxes. The Standard explicitly states that stamp duty and GST are not income of the insurer (s 4.2.3). This clarifies accounting treatment vis-à-vis tax and pass-through obligations.

Practically, insurers must maintain an integrated compliance architecture: actuarial models and valuation assumptions must be aligned with AASB 9 financial instrument designations, AASB 13 fair value techniques, business combination accounting under AASB 3, and the disclosure obligations in Part 17. The Standard’s many cross-references create implementation dependencies: for instance, designating assets FVPL (s 15.2) depends on permitted classifications under AASB 9 and may interact with hedge accounting and capital management policies.

The compilation details and the Table of Standards in the source record an extensive amendment history dating from the original AASB 1023 made in 2004 and many subsequent amending Standards through to 15 December 2022 (Compilation Details). The compilation itself was prepared on 6 February 2023 and applies to annual reporting periods beginning on or after 1 January 2023 but before 1 July 2026.

Key amendment and application milestones recorded in the compilation include:

• Original issue: AASB 1023 dated 15 July 2004, effective for periods beginning on or after 1 January 2005 (Compilation Details table).
• Numerous amending Standards between 2005 and 2022, each altering paragraphs across the Standard. The compilation provides a table of amending Standards with their dates and effective dates (Compilation Details: Table of Standards). Examples include AASB 2005-2, AASB 2005-4, AASB 2009-11, AASB 2010-7, and later AASB 2019-1 and AASB 2021-7.
• The Table of amendments lists the specific paragraphs affected and the amending instruments (e.g. paragraph 15.2 amended by AASB 2005-4, AASB 2009-11 and AASB 2010-7). This gives a traceable history of textual changes and clarifications over time.
• AASB 17 and consequential amendments: AASB 17 was made 19 July 2017 and appears in the Table of Standards with an effective date (beginning 1 January 2023) and consequential amendments, and the compilation notes AASB 17 was amended and will supplant AASB 1023 for periods beginning on or after 1 July 2026 (Compilation Details Table note x). The compilation also lists AASB 2022-8 and AASB 2022-9 as consequential and public sector amendments connected with AASB 17.

The compilation’s Table of amendments gives granular references , showing which paragraphs were amended, added or deleted and by which amending Standards (Table of amendments). For example:

• Paragraphs on assets backing insurance liabilities (15.2, 15.2.1, 15.2.2) were amended multiple times (see Table of amendments entries for 15.2 and 15.2.1).
• Paragraph 17.7 (disclosures on nature and extent of risks) was amended by AASB 2005-10 (see Table of amendments).
• Paragraph 9.1 (liability adequacy test) was amended by AASB 2005-2 (see Table of amendments).

The compilation also includes “General terminology amendments” that updated terminology (e.g. ‘income statement’ to ‘statement of comprehensive income’, ‘balance sheet’ to ‘statement of financial position’) across standards (final section of compilation).

Transitional provisions (Part 18) were amended to provide reliefs: entities need not apply the disclosure requirements to comparative information for periods beginning before 1 January 2005 except for certain disclosures (s 18.1) and there is relief in preparing claims development information earlier than five years before first application (s 18.3).

For preparers and advisers the amendment history conveys two signals: the Standard has evolved in response to other standard-setter developments (notably developments in financial instruments and fair value frameworks) and it will be superseded by AASB 17 (requiring transition planning). The compilation itself is the authoritative, consolidated text through amendments made up to 15 December 2022 (Compilation Details).

The text of AASB 1023 as provided contains no references to judicial decisions, tribunal determinations or administrative enforcement cases. The Standard names no cases and does not cite litigation precedents. Therefore, there is no litigation history recorded within the source to cite.

That absence does not mean the Standard has not been the subject of dispute in practice; it simply means the Standard itself does not catalogue or reference case law. Where measurement choices required by the Standard (for example, central estimate, risk margin, discount rate selection, impairment of reinsurance assets) become contested in auditor reviews, regulator actions or legal claims, those matters would be adjudicated in external forums whose outcomes are not documented within the Standard.

Practitioners should therefore treat litigation risk as an external implementation risk to be mitigated by thorough documentation, conservative and supportable assumptions, clear disclosures (Part 17), and robust audit trails. The Standard increases the visibility of actuarial and management judgements (for example, s 17.6 requires disclosure of the process used to determine assumptions and s 17.2 requires disclosure of central estimate, risk margin, percentage margin and probability of adequacy). Such transparency can reduce but not eliminate dispute risk; the Standard itself offers no adjudicative guidance or jurisdictional enforcement examples.

If clients require jurisdictional litigation precedents or administrative enforcement history relating to the interpretation of AASB 1023, that material must be located in case law databases, regulator publications, or auditor reports, none of which are contained in this Standard.

AASB 1023 contains a number of technical traps and practical implementation frictions that prepare-and-review teams should be alert to. Each “gotcha” below cites the relevant paragraph(s).

1. Attachment date vs contract commencement and premium-in-advance. Premium must be recognised from the attachment date when risk is accepted (s 4.2). Attachment can precede contract commencement (s 4.2.5). Practically this means renewals or broker-negotiated deals accepted before formal commencement can create premium recognition before the reporting period and give rise to premiums in advance that must be included in the unearned premium liability and subject to the liability adequacy test (s 4.2.5; s 9.1). Failure to identify attachment properly can materially misstate revenue and liabilities.

2. Unbundling deposit components only when separable and policy-mismatch risk. Unbundling is required only if the deposit component can be measured separately and the insurer’s accounting policies do not otherwise require recognition of all obligations arising from the deposit component (s 2.4.1(a)). If the deposit component cannot be measured separately, unbundling is prohibited (s 2.4.1(c)). Incorrectly unbundling or failing to unbundle when required forces AASB 9 application errors and can lead to inconsistent treatment of policyholder options or surrender values (s 2.4.4).

3. Risk margin aggregation and diversification effects. The Standard states the risk margin is applied to net outstanding claims for the entity as a whole (s 5.1.8) but also recognises that insurers often estimate margins by class and may recognise an aggregate margin less than the sum of class margins due to diversification (s 5.1.9). Deciding how much diversification to reflect is judgmental and must be disclosed (s 17.2(e), s 17.8(d)(v)). This is a potentially contentious area at audit and regulatory review.

4. Discounting approach and “risk-free” definition. Discount rates must be risk-free, observable and objective (s 6.1). The Standard suggests government bond rates are typically appropriate (s 6.1.2). The choice of curve (which government instruments, interpolation, gaps for long tails) is a model and data choice that materially affects liabilities. For short-tail claims the Standard permits not discounting where present value approximates undiscounted amounts (s 5.1.2-5.1.3). Misapplication or inconsistency in selection of discount curves can skew year-on-year comparability.

5. Gross presentation amplifies balance sheet and income statement volatility. Cedants must show gross premiums, claims and outwards reinsurance expense (s 10.1.2-10.1.3). Reinsurance recoveries are recognised as income and assets, not netted off claims (s 11.1). This increases the scale of amounts on both sides of the accounts and may change ratios used by regulators or investors, even if net economic positions are unchanged.

6. Impairment threshold for reinsurance assets is specific. A reinsurance asset is impaired only when there is objective evidence of a post-recognition event that the cedant may not receive amounts due and that event has a reliably measurable impact (s 12.1.1). This objective evidence test is narrower than some prudential approaches; entities must document evidence and measurement impacts carefully.

7. Liability adequacy test ordering of write-downs. If the liability adequacy test identifies a deficiency, the insurer must recognise it immediately and first write down any related intangible assets and then related deferred acquisition costs before recognising an unexpired risk liability (s 9.1). Failure to apply this ordering will produce incorrect profit and asset balances.

8. Deferred acquisition costs criteria. DAC are assets only where reliably measurable and probable to give rise to future premium revenue to be recognised (s 8.1). Indirect acquisition costs may be difficult to measure reliably (s 8.1.3); over-zealous capitalisation risks later impairment under the liability adequacy test.

9. Requirement to designate backing assets FVPL on first application. Financial assets within AASB 9 scope that back insurance liabilities and are permitted to be FVPL must be designated FVPL on first application or on initial recognition (s 15.2). This has immediate P&L volatility implications and requires coordination with treasury and investment accounting.

10. Data and information flows with cedants and brokers. Reinsurers depend on cedants for premium and claims volumes when estimating inwards reinsurance premium and outstanding claims (s 4.4.8-4.4.9; s 5.2.12). Weak data flow or timing mismatches can materially affect estimates and require conservative provisioning.

11. Disclosures produce comparability headaches. The Standard requires disclosure of the probability of adequacy for both outstanding claims and liability adequacy tests and an explanation where they differ (s 17.2(d), s 17.8(d)(iv)-(e)). Achieving consistency and explaining differences between probabilities used for reserves and for unearned premium testing requires tight governance.

12. Transitional and comparative reliefs are limited. The transition rules (s 18.1-18.3) give relief on comparative disclosures only for early years and have specific limits (for claims development only five years need be shown when first applying). Preparers must plan for historical data assembly if they wish to provide extended development tables with comparatives.

Each of these points is a concrete implementation hazard. Mitigation requires early actuarial engagement, careful design of discounting policies and asset designation decisions, clear documentation of assumptions, and robust data flows with cedants, brokers and reinsurers.

Complying with AASB 1023 requires a coordinated programme across actuarial, finance, treasury, risk and legal functions. Below is a practical checklist drawn directly from the Standard’s requirements and linked paragraphs.

1. Update or adopt accounting policies

• Document accounting policies for insurance contracts, including recognition of premium revenue from attachment date, pattern-of-risk recognition (s 4.2-4.4), treatment of acquisition costs (s 8.1), unbundling deposit components (s 2.4.1-2.4.4) and presentation on a gross basis (s 10.1-10.1.3).
• Ensure policies align with AASB 9 and other referenced standards (Compilation Details; s 3.1).

2. Establish valuation methodologies and governance for reserves

• Adopt a central-estimate methodology and document the statistical basis (s 5.1.4-5.1.5).
• Define and document a risk margin methodology that reflects data quality, model robustness, business characteristics, and diversification treatment; disclose the process and probability of adequacy (s 5.1.6-5.1.11; s 17.2(d), s 17.2(e)).
• Build governance around model validation, data quality, change control and sign-off by the board or designated committees.

3. Set discount-rate policies

• Select objective, observable, risk-free discount curves appropriate to liability terms (s 6.1, s 6.1.2). Document which government bond yields or curves are used and how interpolation/extrapolation is performed.
• Implement procedures to determine when discounting is immaterial for short-term claims (s 5.1.2-5.1.3).

4. Implement liability adequacy test procedures

• Perform the liability adequacy test at portfolio level (s 9.1). Ensure systems capture contract-level or portfolio-level cash flow projections, reinsurance effects and deferred acquisition costs.
• Implement the write-down ordering: related intangible assets first, then DAC, then recognise unexpired risk liability where needed (s 9.1).

5. Reinsurance accounting and recoveries

• Record premiums ceded as outwards reinsurance expense from attachment date (s 10.1). Present amounts gross and separately disclose reinsurance recoveries as assets and income (s 11.1).
• Put in place impairment triggers and tests for reinsurance assets consistent with the objective evidence criterion (s 12.1.1).

6. Asset designation and treasury alignment

• Identify financial assets that back general insurance liabilities and decide FVPL designation where permitted by AASB 9 on first application or recognition (s 15.2). Document investment strategies and governance to justify designation (s 16.1.3(b)(ii) for groups managed on a fair value basis).
• For investment properties that back liabilities, ensure valuation frameworks meet AASB 140 and AASB 13 (s 15.3). For PPE backing liabilities, apply the revaluation model where appropriate (s 15.4).

7. Unbundling and hybrid contracts

• Review contracts for deposit components and embedded derivatives; unbundle where required and apply AASB 9 to deposit components and/or measure embedded derivatives where AASB 9 requires (s 2.3.1-2.4.4). Keep careful contract-level documentation to justify unbundling decisions.

8. Systems and data

• Ensure actuarial and finance systems can handle probability-weighted cash flows, discounting, risk margin aggregation, deferred acquisition cost amortisation, and gross presentation of premium, claims and recoveries.
• Establish processes to capture unclosed business estimates close to reporting date (s 4.5.1-4.5.2).

9. Disclosures and reporting

• Prepare the required disclosures in Part 17: underwriting result (s 17.1), components of net claims incurred with separate disclosure for current-period and reassessment of prior periods (s 17.1(b)), central estimate and risk margin breakdown (s 17.2), process for asset backing decisions (s 17.3), non-insurance contracts disclosures (s 17.4), explanation of recognised amounts (s 17.6), risk disclosures and claims development (s 17.7), and liability adequacy test detail (s 17.8).
• For sensitivity analysis, either provide quantitative sensitivity showing impact on profit or loss and equity for reasonably possible changes or provide qualitative information (s 17.7.5).

10. Transitional planning

• Apply transitional provisions for comparative disclosures (s 18.1-18.3). If applying new measurement or disclosure rules to earlier comparatives, disclose any impracticability in accordance with AASB 108 (s 18.2). For first-time application, claims development prior periods beyond five years may be omitted with disclosure (s 18.3).

11. Controls and audit-readiness

• Prepare robust documentation: actuarial reports, model descriptions, data sources, assumptions and sensitivity testing. Document communications with cedants where reinsurers rely on cedant data (s 4.4.8-4.4.9, s 5.2.12).
• Establish internal review cycles for reserves and disclosures and ensure audit trails are available.

12. Board and management reporting

• Provide management and the board with clear metrics arising from the Standard, including the underwriting result, central estimate and risk margin, probability of adequacy, unearned premium adequacy position, and reconciliation movements (s 17.1, s 17.2, s 17.6).

13. Coordinate with external stakeholders

• Inform auditors early about changes in measurement or presentation, and coordinate with regulators where asset designation or reserve sufficiency may affect prudential outcomes. Consider investor communications around any material change to reported volatility caused by FVPL designation of backing assets (s 15.2).

Following this checklist will not ensure a dispute-free outcome, but it implements the core mechanical steps the Standard requires. The key implementation risks are the subjective judgements in reserves and risk margins, discount-curve specification, and designation of assets FVPL , each must be documented, governed and disclosed in line with the Standard’s requirements (ss 5.1.6-5.1.11, s 6.1, s 15.2, Part 17).